Skip to main content
Medical Devices Venture SA logo

Medical Devices Venture SA — Investor Relations & Filings

Ticker · MLMDV ISIN · FR0014006PT9 LEI · 969500DIDBS9AK697714 PA Financial and insurance activities
Filings indexed 9 across all filing types
Latest filing 2024-02-07 Delisting Announcement
Country FR France
Listing PA MLMDV

About Medical Devices Venture SA

https://www.medicaldevicesventure.com/

Medical Devices Venture SA is a holding company that develops a portfolio of investments in Health Tech and Medtech start-ups. The company provides investment and operational support to early-stage ventures, aiming to transform laboratory projects into commercial leaders. Its support encompasses financing, strategic guidance on patents and certifications, and commercial training. Medical Devices Venture focuses on fostering solutions that combine technology, machine learning, and collaborative platforms, validated through clinical studies, to support patient care.

Recent filings

Filing Released Lang Actions
Résultat de l'offre volontaire de rachat sur les actions MDV au prix de 7,63 EUR par action, suivie d'une radiation des actions MDV du marché Euronext Access+ Paris
Delisting Announcement Classification · 1% confidence The document is a formal announcement dated February 7, 2024, detailing the results of a voluntary takeover bid (offre volontaire de rachat) for MDV shares by Archos, including the low acceptance rate (0.01%) and the subsequent plan for delisting the shares from Euronext Access+ Paris effective February 14, 2024. This content directly relates to a takeover proposal and subsequent corporate action regarding the company's stock market status. This aligns perfectly with the definition of M&A Activity (TAR - Merger Proposals or Takeover Bids). Although it mentions delisting, the primary focus is the outcome of the takeover bid that triggered the delisting process.
2024-02-07 French
Lancement d'une offre volontaire de rachat sur les actions MDV au prix de 7,63 EUR par action, suivie d'une radiation des actions MDV du marché Euronext Access+ Paris
Delisting Announcement Classification · 1% confidence The document explicitly announces the launch of a voluntary tender offer ('offre volontaire de rachat') by a majority shareholder (Archos) to acquire the remaining minority shares, followed by the delisting ('radiation') of the shares from the Euronext Access+ Paris market. This action involves a takeover/acquisition proposal and a subsequent capital structure change (delisting). The key terms are 'offre volontaire de rachat' (tender offer) and 'radiation' (delisting). While it involves a takeover/merger proposal (TAR), the primary focus and action described is the mandatory tender offer triggered by the majority holding, leading to delisting. Since the document details the terms of the offer, the price, the timeline, and the intention to delist, it strongly aligns with a Merger/Takeover Activity (TAR). Although 'Delisting Announcement' (DLST) is relevant due to the stated outcome, the core event initiating the process is the tender offer itself, which falls under TAR (Merger/Takeover Activity). Given the context of a controlling shareholder buying out minorities leading to delisting, TAR is the most appropriate primary classification for the transaction described.
2023-12-27 French
Acquisition de blocs d'actions et BSA MDV par Archos dans le cadre du projet de radiation des actions MDV du marché Euronext Access+ Paris afin de faciliter le financement de MDV auprès de fonds de Pr
M&A Activity Classification · 1% confidence The document announces a significant transaction where the majority shareholder (Archos) acquires blocks of shares and warrants (BSA MDV) from other investors. This action is explicitly linked to a plan to delist MDV shares from the Euronext Access+ Paris market (Radiation MDV). The text details the price per share based on an Independent Expert's Report, the number of shares acquired, and the resulting ownership percentage (>90%), which enables the subsequent mandatory tender offer (Offre) and delisting. This entire sequence—acquisition of shares leading to a mandatory offer and subsequent delisting—falls under corporate actions related to capital structure and potential takeovers/mergers, but the core event described is the acquisition of control leading to a mandatory offer and delisting. Since the document focuses heavily on the acquisition of shares by a controlling party to facilitate a mandatory offer and subsequent delisting, it strongly relates to 'Transaction in Own Shares' (POS) if Archos were buying back shares, or 'M&A Activity' (TAR) due to the mandatory offer context. However, the primary action described is the acquisition of shares by the majority shareholder to gain sufficient control to force a delisting, which is a significant capital/ownership change event. Given the context of gaining control to force a delisting, 'M&A Activity' (TAR) is a strong candidate, but the specific mechanism described—a controlling shareholder buying shares to reach a threshold for a mandatory offer and delisting—is often classified under capital changes or takeover activity. Since the document explicitly mentions the 'Offre' (tender offer) that will follow, 'TAR' (M&A Activity) is the most appropriate fit for a transaction leading to a mandatory offer and change in control/structure, even if it's an internal restructuring leading to delisting. The document is an announcement of this transaction, not a formal regulatory filing like a 10-K or an ER.
2023-11-30 French
Résultats premier semestre 2023
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive report detailing the financial results for the first half of 2023 (H1 2023). It includes a detailed breakdown of business activities for various subsidiaries, a consolidated income statement, balance sheet data, and management commentary on performance and outlook. Since it covers a period shorter than a full fiscal year and contains substantive financial statements and analysis, it is classified as an Interim/Quarterly Report. H1 2023
2023-08-01 French
Date de Publication des Résultats du 1er semestre 2023
Report Publication Announcement Classification · 1% confidence The document is a short announcement dated July 26, 2023, stating that the company's 'résultats du 1er semestre 2023' (first half 2023 results) will be published on August 1, 2023, before the market opens. Since the document is very short (760 characters) and its sole purpose is to announce the future publication date of a financial report (the interim results), it fits the definition of a Report Publication Announcement (RPA). It is not the actual Interim Report (IR) itself.
2023-07-26 French
Résultats 2022 et Perspectives 2023
Earnings Release Classification · 1% confidence The document is titled "Résultats 2022 et Perspectives 2023" (2022 Results and 2023 Outlook) and contains a synthetic consolidated income statement and balance sheet comparing 2022 results to 2021 results. This structure, detailing financial performance for a full fiscal year (ending 31/12/2022), strongly indicates an Annual Report or a document closely related to annual financial disclosure. Since it presents the full year's results and outlook, it aligns best with the scope of an Annual Report (10-K), although it might be a press release summarizing it. Given the inclusion of detailed comparative financial tables (Compte de résultat Synthétique and Principaux éléments bilanciels consolidés), it functions as the primary annual financial disclosure. If this were a quarterly report, it would typically be labeled as such (Interim Report/IR). Since it covers the full year and includes comprehensive financial data, 10-K is the most appropriate classification for the underlying report type being summarized, or ER if it were purely a press release, but the depth suggests more than just an Earnings Release (ER). However, since the text is in French and appears to be a press release announcing the results (dated March 23, 2022, reporting on 2022 results), it is most accurately classified as an Earnings Release (ER) summarizing the annual performance, or potentially an Interim Report (IR) if the company uses this format for its annual summary release, but ER is standard for initial result announcements. Given the context of 'Résultats 2022', it is the primary announcement of the annual figures, fitting the ER definition best, even if the data covers the full year. FY 2022
2023-03-23 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.